New Delhi Medicos Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
- Revenue Growth 10.56%
- Profit Growth -25.11%
- Ebitda -382.78%
- Net Worth 8.68%
- Total Assets -13.55%
About New Delhi Medicos
New Delhi Medicos Private Limited (NDMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 March 2009 and has a history of 15 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 M.
Raj Gupta, Pardeep Singh, Atul Gupta, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52390DL2009PTC188699
- Company No.
188699
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does New Delhi Medicos Private Limited offer?
New Delhi Medicos Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Immunosuppressive Drugs.
Who are the key members and board of directors at New Delhi Medicos?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Gupta  | Director | 23-Mar-2009 | Current |
| Pardeep Singh | Director | 23-Mar-2009 | Current |
| Atul Gupta | Director | 30-Mar-2009 | Current |
| Nirmala Gupta | Director | 03-Oct-2018 | Current |
Financial Performance of New Delhi Medicos.
New Delhi Medicos Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.56% increase. The company also saw a substantial fall in profitability, with a 25.11% decrease in profit. The company's net worth moved up by a moderate rise of 8.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New Delhi Medicos?
Unlock access to New Delhi Medicos's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Atlas Biotec Private LimitedRaj Gupta and Pardeep Singh are mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Oct 2011 | Others | ₹1.00 M | Open |
How Many Employees Work at New Delhi Medicos?
New Delhi Medicos has a workforce of 15 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Delhi Medicos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Delhi Medicos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
